Ready Med Review

What Ready Med charges

• Semaglutide: $199/mo — per month after a $99 first month; the membership ships every sixty to ninety days rather than monthly
• Semaglutide: $297/mo — per month, printed five times in the page body; the hero of the same page reads "Only $249 per Month"
• Tirzepatide: $449/mo — per month, printed three times in the page body; the hero of the same page reads "Only $297 per month - No Hidden Fees"

Ready Med also sells 3 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), Sermorelin and GHK-Cu.

The letter names its own website and its own address

The June 2026 letter opens by citing the address of this site, and its recipient block reads Ready Med at a street address in Clearwater, Florida.

That is the same address the site prints, and the letter carries the same personal mail account the site publishes as its contact.

The identification comes from the document itself rather than from a name that happened to match a table row.

One product, two prices, on one page

Its tirzepatide page carries one figure in the hero banner and a different one printed three times in the body, with nothing saying which supersedes the other.

The hero figure also reappears further down the same page as a heading over a block about two other drugs, so which product it belongs to is genuinely ambiguous rather than merely sloppy.

The same shape repeats on its oral semaglutide page — a hero figure and a different body figure printed five times. Both sides are recorded on both pages, and neither conflict is resolved here because the site does not resolve it.

It asks itself which states it serves and answers with something else

Its FAQ contains the question "What states is Ready Med available?"

The text underneath that question describes its video-call software.

There is no state answer anywhere on the site, so no coverage is recorded and a reader cannot confirm their own state.

What is priced, what is not, and who is behind it

Its peptide products — BPC-157, sermorelin, GHK-Cu and a product called Wolverine — carry no price at all, and Wolverine is a BPC-157 and TB-500 blend, so no single-compound price could have been taken from it even if it had one.

Dose upgrades add a flat monthly charge on top, which is an add-on rather than a price for a product, so it is not recorded as one.

No legal entity is named anywhere in its terms or its privacy policy, no pharmacy is named, and its published contact is a personal mail account.

FDA disclosure

Ready Med received an FDA warning letter issued June 2026. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.

How we verified this

• Read both conflicting product pages end to end and recorded both figures on each, without choosing between them.
• Noted where the hero figure reappears as a heading over a block about two other drugs, which is why that conflict is left standing rather than explained away.
• Read the FAQ entry asking which states it is available in and confirmed the answer beneath it describes its video-call software.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Confirmed the June 2026 federal warning letter from its own opening line, which names the seller's website, and from a recipient block giving the same Clearwater, Florida street address and the same personal mail account the site publishes.